Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 14, 2017; 23(6): 1090-1097
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1090
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1090
Figure 3 Case 8.
Computed tomography images before (A, C) and after (B, D) four courses of modified docetaxel, cisplatin and capecitabine (DCX) (mDCX). Left supraclavicular nodes (A, B) and para-aortic nodes (C, D) became undetectable.
- Citation: Maeda O, Matsuoka A, Miyahara R, Funasaka K, Hirooka Y, Fukaya M, Nagino M, Kodera Y, Goto H, Ando Y. Modified docetaxel, cisplatin and capecitabine for stage IV gastric cancer in Japanese patients: A feasibility study. World J Gastroenterol 2017; 23(6): 1090-1097
- URL: https://www.wjgnet.com/1007-9327/full/v23/i6/1090.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i6.1090